|
Re: Resverlogix H2 2018 events
|
4
|
Resverlogix Corp.
|
Aug 28, 2018 04:33PM
|
|
Re: Fabry trial news, Halifax and Alberta's Children't Hospital slated....
|
4
|
Resverlogix Corp.
|
Jun 14, 2017 10:44AM
|
|
ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Jul 14, 2017 01:49PM
|
|
Re: RVX AGM 12/22/2020 - rough transcript
|
4
|
Resverlogix Corp.
|
Jan 06, 2021 10:55AM
|
|
Re: Is it just coincidental......
|
4
|
Resverlogix Corp.
|
Oct 13, 2017 07:03PM
|
|
Re: why present in London?
|
4
|
Resverlogix Corp.
|
Oct 05, 2016 02:20PM
|
|
AGM Sept. 12, 2018
|
4
|
Resverlogix Corp.
|
Jun 29, 2018 04:45PM
|
|
Re: The Pinks Down .06
|
4
|
Resverlogix Corp.
|
Feb 10, 2016 12:23PM
|
|
Re: My guesstimate for Patient Years...
|
4
|
Resverlogix Corp.
|
Jun 21, 2019 11:06AM
|
|
Re: Amarin / Mineral Oil
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 04:11PM
|
|
Re: BETonMACE Enrollment....and another question for BDZ
|
4
|
Resverlogix Corp.
|
Feb 08, 2019 05:31PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 10:08AM
|
|
Re: Zenith abstract to be presented at AACR meeting 11/30
|
4
|
Zenith Epigenetics
|
Nov 25, 2016 10:31AM
|
|
Re: dependent on RVX?
|
4
|
Zenith Epigenetics
|
Apr 03, 2018 11:30AM
|
|
Re: Shrinking MACE event rate
|
4
|
Resverlogix Corp.
|
Jan 19, 2019 05:52PM
|
|
Resverlogix presenting at Vascular Discovery 2019 next week
|
4
|
Resverlogix Corp.
|
May 10, 2019 04:49PM
|
|
Re: I wonder if this is common with Biotechs?
|
4
|
Resverlogix Corp.
|
Jul 05, 2017 02:11PM
|
|
Invokana CREDENCE Renal Outcomes Trial Stopped Early for Efficacy
|
4
|
Resverlogix Corp.
|
Jul 16, 2018 05:23PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 09:28AM
|
|
Re: AHA 2018
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 05:02PM
|
